GSK3B and myotonic dystrophy type 1: We used GSK-3β inhibition to provide indirect insight of CUGBP1 activity and found that GSK-3β was inhibited to a lesser extent in DM1 skeletal muscle, potentially suggesting augmented CUGBP1 activity that was unaffected by exercise (Figure 3 and Figure 6).